Founded Year
1985Stage
PIPE | IPOAbout Theratech
Developer of advanced, controlled release drug delivery products which administer drugs through the skin, by oral delivery to the gastrointestinal tract, through tissues in the oral cavity, and by other means. Products provide significant advantages over existing controlled release drug delivery products and conventional oral, injectable, and continuous infusion methods by increasing efficacy, safety, bioavailability, and patient compliance and comfort. Research and development are focused on design and development of improved delivery systems for off-patent and proprietary drugs, thus avoiding much of the risk and expense associated with new drug discovery.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Theratech Frequently Asked Questions (FAQ)
When was Theratech founded?
Theratech was founded in 1985.
Where is Theratech's headquarters?
Theratech's headquarters is located at 417 Wakara Way, Salt Lake City.
What is Theratech's latest funding round?
Theratech's latest funding round is PIPE.
Who are the investors of Theratech?
Investors of Theratech include SR One.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
